Details

Autor(en) / Beteiligte

• Yoon, Jungho
• Park, Taemook
• Kim, Ahram
• Song, Heeeun
• Park, Byung‐Joo
• Ahn, Hee‐Seop
• Go, Hyeon‐Jeong
• Kim, Dong‐Hwi
• Lee, Joong‐Bok
• Park, Seung‐Yong
• Song, Chang‐Seon
• Lee, Sang‐Won
• Choi, In‐Soo

Titel

First report of equine parvovirus‐hepatitis and equine hepacivirus coinfection in horses in Korea

Ist Teil von

• Transboundary and emerging diseases, 2022-09, Vol.69 (5), p.2735-2746

Ort / Verlag

Germany: Hindawi Limited

Erscheinungsjahr

2022

Quelle

Wiley Online Library - AutoHoldings Journals

Beschreibungen/Notizen

• Equine parvovirus‐hepatitis (EqPV‐H) and equine hepacivirus (EqHV) are etiologically associated with Theiler's disease (TD), causing fulminant equine hepatitis, but the transmission route and co‐infection effect remain unclear. We determined EqPV‐H and EqHV prevalence and coinfection rate in 160 serum and 114 faecal samples using nested polymerase chain reaction. Amino acid and nucleotide analyses were performed and phylogenetic trees were constructed. By measuring liver‐specific parameters (AST, GGT, TBIL and A/G ratio), hepatopathological changes in viremia status were compared. We found a high prevalence (EqPV‐H: 10.6% in serum, 5.3% in faeces; EqHV: 8.1% in serum) and coinfection rate (35.3% in EqPV‐H) of TD‐causing agents. The newly identified EqPV‐H genomes showed high nucleotide and amino acid similarities with previously reported strains in the USA, China and Austria. In phylogenetic tree and recombination analysis, a natural recombination event was confirmed between Chinese and Korean strains. In the EqPV‐H or EqHV viremic horses, AST was significantly elevated and at least two liver‐specific parameters were outside the reference intervals in 43.5% (10/23) of horses. To our knowledge, this is the first prevalence field study of EqPV‐H and EqHV using both serum and faeces, providing further evidence of faecal‐oral transmission of TD. These epidemiologic and clinicopathologic analyses specify the risk factors of TD infection and promote disease prevention strategy.